stockportfolio.pro
Merck & Co., Inc. P/E Ratio 2007–2025
Merck & Co., Inc. (MRK) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -1.7%/yr over 18 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 14.23 | +1.6% |
| FY 2024 | 14.01 | -98.1% |
| FY 2023 | 719.97 | +4017.2% |
| FY 2022 | 17.49 | +34.9% |
| FY 2021 | 12.96 | -45.1% |
| FY 2020 | 23.59 | +15.7% |
| FY 2019 | 20.40 | -18.2% |
| FY 2018 | 24.94 | -47.4% |
| FY 2017 | 47.45 | +45.2% |
| FY 2016 | 32.67 | +27.4% |
| FY 2015 | 25.64 | +150.5% |
| FY 2014 | 10.24 | -53.5% |
| FY 2013 | 22.03 | +57.2% |
| FY 2012 | 14.02 | +14.5% |
| FY 2011 | 12.24 | -83.3% |
| FY 2010 | 73.46 | +1789.9% |
| FY 2009 | 3.89 | -10.2% |
| FY 2008 | 4.33 | -77.7% |
| FY 2007 | 19.45 | — |
Source: Merck & Co., Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Merck & Co., Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMerck & Co., Inc. — frequently asked questions
What is Merck & Co., Inc.'s price-to-earnings ratio?
Merck & Co., Inc. (MRK) reported price-to-earnings ratio of 14.23 for fiscal year 2025, per its SEC filings.
How has Merck & Co., Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, MRK's price-to-earnings ratio declined at roughly 1.7% per year (compound annual rate), from 19.45 to 14.23.
Where does this data come from?
Figures are computed from Merck & Co., Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.